|
[1]
|
Bullón, P., Cano-García, F.J., Alcocer-Gómez, E., et al. (2017) Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients? Antioxidants & Redox Signaling, 27, 269-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hoseini, Z., Sepahvand, F., Rashidi, B., et al. (2018) NLRP3 Inflammasome: Its Regulation and Involvement in Atherosclerosis. Journal of Cellular Physiology, 233, 2116-2132. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Toldo, S., Mezzaroma, E., Mauro, A.G., et al. (2015) The Inflammasome in Myocardial Injury and Cardiac Remodeling. Antioxidants & Redox Signaling, 22, 1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Rongbin, Z., Yazdi, A.S., Philippe, M., et al. (2011) A Role for Mitochondria in NLRP3 Inflammasome Activation. Nature, 469, 221. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Franchi, L. and Núñez, G. (2012) Immunology. Orchestrating Inflammasomes. Science, 337, 1299-1300. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Elliott, E.I. and Sutterwala, F.S. (2015) Initiation and Perpetuation of NLRP3 Inflammasome Activation and Assembly. Immunological Reviews, 265, 35-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Stutz, A., Kolbe, C.C., Stahl, R., et al. (2017) NLRP3 Inflammasome Assembly Is Regulated by Phosphorylation of the Pyrin Domain. Journal of Experimental Medicine, 214, 1725. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Frangogiannis, N.G. (2014) The Inflammatory Response in Myocardial Injury, Repair, and Remodelling. Nature Reviews Cardiology, 11, 255-265. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hughes, M.M. and O’neill, L.J. (2018) Metabolic Regulation of NLRP3. Immunological Reviews, 281, 88-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Yu, X.J., Zhang, D.M., Jia, L.L., et al. (2015) Inhibition of NF-kappaB Activity in the Hypothalamic Paraventricular Nucleus Attenuates Hypertension and Cardiac Hypertrophy by Modulating Cytokines and Attenuating Oxidative Stress. Toxicology and Applied Pharmacology, 284, 315-322.
|
|
[11]
|
Qi, J., Yu, X.J., Shi, X.L., et al. (2015) NF-κB Blockade in Hypothalamic Paraventricular Nucleus Inhibits High- Salt-Induced Hypertension through NLRP3 and Caspase-1. Cardiovascular Toxicology, 16, 345-354. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Krishnan, S.M., et al. (2014) IL-1β and IL-18: Inflammatory Markers or Mediators of Hypertension? British Journal of Pharmacology, 171, 5589-5602. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Toshiro, F. (2014) Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems. Journal of the American Society of Nephrology, 25, 1148-1155. [Google Scholar] [CrossRef]
|
|
[14]
|
Lin, L., Phillips, W.E. and Jr., R.M. (2009) Intrarenal Angiotensin II Is Associated with Inflammation, Renal Damage, and Dysfunction in Dahl Salt-Sensitive Hypertension. Journal of the American Society of Hypertension, 3, 306-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, X., Ian, M.P. and Mehta, J.L. (2011) LOX-1 and Angiotensin Receptors, and Their Interplay. Cardiovascular Drugs and Therapy, 25, 401-417. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gan, W., Ren, J., Li, T., et al. (2017) The SGK1 Inhibitor EMD638683, Prevents Angiotensin II-Induced Cardiac Inflammation and Fibrosis by Blocking NLRP3 Inflammasome Activation. Biochimica et Biophysica Acta, 1864, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Galkina, E. and Ley, K. (2008) Immune and Inflammatory Mechanisms of Atherosclerosis. Annual Review of Immunology, 27, 165-197. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Cochain, C. and Zernecke, A. (2016) Protective and Pathogenic Roles of CD8+ T Cells in Atherosclerosis. Basic Research in Cardiology, 111, 71. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lu, X. and Kakkar, V. (2014) Inflammasome and Atherogenesis. Current Pharmaceutical Design, 20, 108-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zheng, F., Xing, S., Gong, Z., et al. (2014) Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice. Mediators of Inflammation, 2014, Article ID: 507208. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Peter, D., Hajime, K., Rayner, K.J., et al. (2010) NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals. Nature, 464, 1357-1361. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hendrikx, T., Jeurissen, M.L., Van Gorp, P.J., et al. (2015) Bone Marrow-Specific Caspase-1/11 Deficiency Inhibits Atherosclerosis Development in Ldlr-/-Mice. Febs Journal, 282, 2327-2338. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Amna, A., Dominique, C., Mahmood, D.F.D., et al. (2014) Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet. Circulation, 6, 6-7.
|
|
[24]
|
Baldrighi, M., Mallat, Z. and Li, X. (2017) NLRP3 Inflammasome Pathways in Atherosclerosis. Atherosclerosis, 267, 127. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Lu, J., et al. (2011) Oxidative Stress and Lectin-Like ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis. Antioxidants & Redox Signaling, 15, 2301-2333. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Nvk, P., Karathanasis, S.K., Ding, Z., et al. (2017) LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation. Journal of the American College of Cardiology, 69, 2759. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Sidhu, R.K. (2016) Association between Acute Myocardial Infarction and Periodontitis: A Review of the Literature. Journal of the International Academy of Periodontology, 18, 23.
|
|
[28]
|
Jung, M., Ma, Y., Iyer, R.P., et al. (2017) IL-10 Improves Cardiac Remodeling after Myocardial Infarction by Stimulating M2 Macrophage Polarization and Fibroblast Activation. Basic Research in Cardiology, 112, 33. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Rienks, M., Carai, P., Bitsch, N., et al. (2017) Sema3A Promotes the Resolution of Cardiac Inflammation after Myocardial Infarction. Basic Research in Cardiology, 112, 42. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yellon, D. and Hausenloy, D. (2007) Myocardial Reperfusion Injury—Reply. New England Journal of Medicine, 357, 1121-1135. [Google Scholar] [CrossRef]
|
|
[31]
|
Abbate, A., Van Tassell, B.W., Seropian, I.M., et al. (2014) Interleukin-1β Modulation Using a Genetically Engineered Antibody Prevents Adverse Cardiac Remodelling Following Acute Myocardial Infarction in the Mouse. European Journal of Heart Failure, 12, 319-322. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Takahashi, M. (2011) Role of the Inflammasome in Myocardial Infarction. Trends in Cardiovascular Medicine, 21, 37-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Van Hout, G.P., Bosch, L., Ellenbroek, G.H., et al. (2016) The Selective NLRP3-Inflammasome Inhibitor MCC950 Reduces Infarct Size and Preserves Cardiac Function in a Pig Model of Myocardial Infarction. European Heart Journal, 38, 828. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Marchetti, C., Chojnacki, J., Toldo, S., et al. (2014) A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury after Ischemia-Reperfusion in the Mouse. Journal of Cardiovascular Pharmacology, 63, 316. [Google Scholar] [CrossRef]
|
|
[35]
|
Liu, Y., Lian, K., Zhang, L., et al. (2014) TXNIP Mediates NLRP3 Inflammasome Activation in Cardiac Microvascular Endothelial Cells as a Novel Mechanism in Myocardial Ischemia/Reperfusion Injury. Basic Research in Cardiology, 109, 415. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Masanori, K., Masafumi, T., Takeki, H., et al. (2011) Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury. Circulation, 123, 594-604. [Google Scholar] [CrossRef]
|
|
[37]
|
Yoshiyuki, I., Yoshikazu, Y. and Masafumi, T. (2013) Role of the Inflammasome in Inflammatory Responses and Subsequent Injury after Hepatic Ischemia-Reperfusion Injury. Hepatology, 58, 2212. [Google Scholar] [CrossRef] [PubMed]
|